Genomic Valley Biotech Profile
Key Indicators
- Authorised Capital ₹ 9.00 Cr
as on 05-07-2024
- Paid Up Capital ₹ 3.05 Cr
as on 05-07-2024
- Company Age 30 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.74 Cr
as on 05-07-2024
- Revenue -26.74%
(FY 2022)
- Profit 98.33%
(FY 2022)
- Ebitda -173.68%
(FY 2022)
- Net Worth -35.86%
(FY 2022)
- Total Assets -50.15%
(FY 2022)
About Genomic Valley Biotech
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 539206.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 9.00 Cr and a paid-up capital of Rs 3.05 Cr.
The company has closed loans amounting to ₹3.74 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Genomic Valley Biotech Limited India are Anupam Aditya as COMPANY SECRETARY and Yogesh Agrawal as Cfo. Ashok Kumar, Yogesh Agrawal, Parul Agrawal, and One other member serve as directors at the Company.
- CIN/LLPIN
L01122HR1994PLC033029
- Company No.
033029
- Stock Symbol
BSE : 539206
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
16 May 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Jhajjar, Haryana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Genomic Valley Biotech Limited offer?
Genomic Valley Biotech Limited offers a wide range of products and services, including Fresh, Dried & Preserved Vegetables, Chilli, Exotic Vegetables.
Who are the key members and board of directors at Genomic Valley Biotech?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupam Aditya | Company Secretary | 31-Mar-2023 | Current |
| Yogesh Agrawal | CFO | 30-Jun-2023 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Mishra  | Director | 30-Jun-2023 | Current |
| Ashok Kumar | Additional Director | Current | |
| Parul Agrawal | Additional Director | 20-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Genomic Valley Biotech.
Genomic Valley Biotech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 26.74% decrease. The company also saw a substantial improvement in profitability, with a 98.33% increase in profit. The company's net worth observed a substantial decline by a decrease of 35.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Genomic Valley Biotech?
In 2022, Genomic Valley Biotech had a promoter holding of 67.85% and a public holding of 32.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Genomic Valley Bharat Private LimitedActive 1 year 4 monthsYogesh Agrawal and Parul Agrawal are mutual person
- Eyoge Technologies Private LimitedActive 30 years 5 months
Yogesh Agrawal and Parul Agrawal are mutual person
- Rishikesh School Of Yoga FoundationActive 1 year 3 months
Yogesh Agrawal and Parul Agrawal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Apr 2021 | ₹2.26 Cr | Satisfied |
Others Creation Date: 30 Apr 2019 | ₹1.48 Cr | Satisfied |
How Many Employees Work at Genomic Valley Biotech?
Unlock and access historical data on people associated with Genomic Valley Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Genomic Valley Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genomic Valley Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
